Vantage Investment Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$2K Hold
50
– – ﹤0.01% 698
2018
Q2
$2K Hold
50
– – ﹤0.01% 695
2018
Q1
$2K Sell
50
-10
-17% -$500 ﹤0.01% 725
2017
Q4
$3K Hold
60
– – ﹤0.01% 722
2017
Q3
$3K Hold
60
– – ﹤0.01% 699
2017
Q2
$2K Sell
60
-33
-35% -$1.3K ﹤0.01% 701
2017
Q1
$4K Hold
93
– – ﹤0.01% 647
2016
Q4
$2K Hold
93
– – ﹤0.01% 695
2016
Q3
$1K Sell
93
-5
-5% -$57 ﹤0.01% 728
2016
Q2
$1K Buy
98
+6
+7% +$53 ﹤0.01% 761
2016
Q1
$1K Sell
92
-97
-51% -$487 ﹤0.01% 747
2015
Q4
$1K Sell
189
-185
-49% -$1.18K ﹤0.01% 730
2015
Q3
$2K Buy
+374
New +$3.92K ﹤0.01% 699

Other funds holding CC

Vantage Investment Advisors's CC Position: Q3 2018 in Review

Vantage Investment Advisors held its Chemours (CC) position steady in Q3 2018 at 50 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #698.

Vantage Investment Advisors first reported a position in CC in Q3 2015 and has held it in 13 quarters since. The position peaked at $4K in Q1 2017. 551 funds tracked by Wall St. Rank hold CC as of Q3 2018.

  • Vantage Investment Advisors held 50 shares of Chemours worth $2K as of Q3 2018.
  • Vantage Investment Advisors left its Chemours share count unchanged in Q3 2018.
  • Chemours made up ﹤0.01% of Vantage Investment Advisors's portfolio in Q3 2018, its #698 holding.
  • Vantage Investment Advisors first reported a position in Chemours in Q3 2015 and has held it in 13 quarters since.
  • Vantage Investment Advisors's Chemours position peaked at $4K in Q1 2017.
  • 551 funds tracked by Wall St. Rank held Chemours as of Q3 2018.

Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.